0001628280-23-036052.txt : 20231101
0001628280-23-036052.hdr.sgml : 20231101
20231101172953
ACCESSION NUMBER: 0001628280-23-036052
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231019
FILED AS OF DATE: 20231101
DATE AS OF CHANGE: 20231101
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DE GREEF RODERICK
CENTRAL INDEX KEY: 0001241181
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36362
FILM NUMBER: 231369342
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOLIFE SOLUTIONS INC
CENTRAL INDEX KEY: 0000834365
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 943076866
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3303 MONTE VILLA PARKWAY
STREET 2: SUITE 310
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4254011400
MAIL ADDRESS:
STREET 1: 3303 MONTE VILLA PARKWAY
STREET 2: SUITE 310
CITY: BOTHELL
STATE: WA
ZIP: 98021
FORMER COMPANY:
FORMER CONFORMED NAME: BIOLIFE SOLUTION INC
DATE OF NAME CHANGE: 20030113
FORMER COMPANY:
FORMER CONFORMED NAME: CRYOMEDICAL SCIENCES INC
DATE OF NAME CHANGE: 19920703
4
1
wk-form4_1698874183.xml
FORM 4
X0508
4
2023-10-19
0
0000834365
BIOLIFE SOLUTIONS INC
BLFS
0001241181
DE GREEF RODERICK
3303 MONTE VILLA PARKWAY
SUITE 310
BOTHELL
WA
98021
1
1
0
0
President and CEO
0
Common Stock
2023-10-19
4
A
0
394856
A
442539
D
Restricted Stock Award
0
2023-10-19
4
A
0
394856
0
A
Common Stock
394856
394856
D
The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. The restricted stock was granted to the reporting person as part of their employment agreement.
This reflects the total amount beneficially owned by the reporting person as of October 19, 2023. Previous Form 4's filed by the reporting person before October 19, 2023 did not reflect the acquisition of 2,421 shares.
The restricted stock was granted pursuant to the Executive Employment Agreement. The restricted stock will vest in equal annual installments so long as the reporting owner remains employed by the registrant through January 1, 2027.
/s/ Roderick de Greef
2023-11-01